As of Jun 23
| +0.45 / +1.18%|
The 10 analysts offering 12-month price forecasts for Medicines Co have a median target of 57.00, with a high estimate of 80.00 and a low estimate of 44.00. The median estimate represents a +47.67% increase from the last price of 38.60.
The current consensus among 9 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.